7.1 TIME Principle & Wound Bed Preparation Framework

7.1 TIME Principle & Wound Bed Preparation Framework

Core Clinical Principle: Wound healing cannot proceed in an unprepared wound bed. The Certified Wound Specialist Physician (CWSP) does not simply apply topical dressings to cover a defect, but systematically dismantles cellular and biochemical barriers—nonviable tissue, persistent infection/biofilm, exudate imbalance, cellular senescence, and systemic impairments—transforming a hostile, catabolic microenvironment into an anabolic, regenerative state.

---

The Biological Revolution: George Winter (1962) & Moist Wound Healing Dynamics

For centuries, clinical medicine operated under the erroneous belief that wounds should be exposed to air to "dry out" and form a hard scab. In 1962, British experimental pathologist George D. Winter published a landmark paper in Nature that revolutionized wound care science. Using a standardized young domestic pig (Sus scrofa) model—chosen because porcine skin closely parallels human epidermal turnover, dermal thickness, hair follicle distribution, and vascular architecture—Winter created superficial, partial-thickness blister wounds and compared open air exposure against occlusion with a clear polyethylene film.

+-------------------------------------------------------------------------+
|          EPIDERMAL RE-EPITHELIALIZATION KINETICS (WINTER, 1962)          |
+-------------------------------------------------------------------------+
| DRY / EXPOSED HEALING:                                                  |
|   Air Exposure -> Dermal Desiccation -> Hard Dry Eschar (Scab)          |
|   Keratinocytes MUST burrow deep under eschar along moist plane         |
|   Slower resurfacing under a dry scab                                    |
+-------------------------------------------------------------------------+
| MOIST / OCCLUSIVE HEALING:                                              |
|   Polyethylene Film -> Prevents Water Evaporation -> Fluid Retention    |
|   Keratinocytes glide horizontally across superficial moist dermis      |
|   Resurfacing about twice as fast as air-exposed wounds                  |
+-------------------------------------------------------------------------+

1. Cellular Mechanics of Keratinocyte Migration

Under air-exposed dry conditions, evaporative water loss desiccates the exposed upper dermis and stratum spinosum within hours. The resulting dry crust (eschar/scab) consists of dehydrated erythrocytes, coagulated plasma proteins, and nonviable collagen bundles:

• The Burrowing Phenomenon: Keratinocytes at the wound margin cannot adhere to or crawl over dry, desiccated tissue. To find a hydrated substrate containing intact fibronectin and Type IV collagen, migrating basal keratinocytes must secrete matrix metalloproteinases (specifically MMP-1 / interstitial collagenase) to cleave a mechanical path deep beneath the dry scab, directly above the viable dermal capillary bed. This deep burrowing destroys viable upper dermal matrix, increases tissue loss, and delays wound closure.
• The Horizontal Leap: Under moist occlusive or semi-occlusive dressings, local hydration preserves the viability of the upper papillary dermis. Basal keratinocytes undergo phenotypic activation (dissolving hemidesmosomal BP180/BP230 contacts via integrin alpha-6/beta-4 phosphorylation) and migrate horizontally across the superficial wound interface. Epithelial resurfacing proceeds about twice as fast as under a dry scab.

2. Preservation of Endogenous Growth Factors & Autolysis

In an open, desiccating wound, soluble cytokines and growth factors are trapped within the dehydrated fibrin matrix, denatured, and rendered biologically inert. A moist wound environment maintains endogenous peptides—such as Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (bFGF), and Vascular Endothelial Growth Factor (VEGF)—in an active, hydrated state, facilitating receptor-ligand interactions. Furthermore, endogenous neutral proteases and collagenases synthesized by macrophages and neutrophils require an aqueous medium to diffuse and digest nonviable tissue (autolytic debridement); drying the bed halts all enzymatic turnover.

3. Nociceptive Shielding & Pain Reduction

Desiccation and exposure to ambient air stimulate exposed dermal unmyelinated C-fibers and lightly myelinated A-delta free nerve endings. Moisture-retentive dressings act as a physical buffer, bathing nerve endings in physiological, isotonic fluid and shielding them from air currents, shear, and mechanical friction. Patients treated with modern moist wound dressings experience dramatic reductions in both resting pain and dressing-change discomfort compared to dry gauze therapies.

Comparative Analysis: Dry vs. Moist Wound Healing Environment

---

The Classic Schultz et al. TIME Framework (2003)

In 2003, an international consensus panel led by Schultz, Sibbald, Falanga, and colleagues formulated the TIME Framework. Designed as a systematic clinical diagnostic and therapeutic decision tool, TIME organizes the pathophysiology of chronic, non-healing wounds into four actionable components:

+-------------------------------------------------------------------------+
|                        THE CLASSIC TIME FRAMEWORK                       |
+-------------------------------------------------------------------------+
| [T] TISSUE NONVIABLE     -> Remove slough, eschar, and necrotic debris  |
|                             Goal: Viable, vascularized granulation bed  |
+-------------------------------------------------------------------------+
| [I] INFECTION / INFLAMM. -> Suppress biofilm, bioburden, and cytokines  |
|                             Goal: Balanced flora, resolved inflammation |
+-------------------------------------------------------------------------+
| [M] MOISTURE IMBALANCE   -> Balance exudate; prevent maceration/dryness |
|                             Goal: Optimized moist microenvironment      |
+-------------------------------------------------------------------------+
| [E] EDGE NON-ADVANCING   -> Excise epibole, address cellular senescence |
|                             Goal: Migrating epithelial tongue           |
+-------------------------------------------------------------------------+

1. T: Tissue Nonviable or Deficient

Nonviable tissue presents along a spectrum from yellow/white fibrinous slough (dead neutrophils, cellular debris, denatured collagen, and bacterial glycocalyx) to black/brown, hard, leathery eschar (full-thickness dehydrated necrosis).

• Pathophysiological Consequence: Devitalized tissue acts as a mechanical obstruction preventing keratinocyte migration and wound contraction. Biochemically, necrotic tissue serves as an uninhibited culture medium and physical shelter for bacterial biofilms, while continuously releasing damage-associated molecular patterns (DAMPs) that recruit endless waves of neutrophils, perpetuating a destructive cycle of inflammation.
• Clinical Action: Debridement (selective sharp, surgical excisional, enzymatic, autolytic, mechanical, or biosurgical) to unroof pockets, eliminate bacterial reservoirs, and expose viable, bleeding tissue.

2. I: Infection / Inflammation

Chronic wounds exist along a microbiological spectrum: Contamination (bacteria present without replication) -> Colonization (replicating flora without host tissue damage) -> Critical Colonization / Local Infection (bioburden delays healing without classic systemic symptoms) -> Invasive Infection (microorganisms penetrate viable tissue, causing cellulitis, phlegmon, or osteomyelitis).

• The Biofilm Paradigm: A meta-analysis estimated that about 78% of chronic wounds harbor bacterial biofilms—organized polymicrobial communities encased within an extracellular polymeric substance (EPS) matrix composed of polysaccharides, extracellular DNA, and structural proteins. Biofilms confer phenotypic antimicrobial resistance, rendering bacteria 100 to 1,000 times more resistant to systemic antibiotics and standard antiseptics compared to planktonic bacteria.
• Clinical Diagnostic Tools:
  • NERDS Criteria (identifies local infection / critical colonization): Non-healing wound, Exudative increase, Red friable granulation tissue, Debris/slough on wound bed, Smell/odor.
  • STONEES Criteria (identifies deep invasive tissue infection requiring systemic antimicrobials): Size increasing, Temperature elevated (>3°F difference), Os (probe-to-bone positive), New satellite breakdown, Erythema/Edema extending >2 cm, Exudate copious/purulent, Smell.
• Clinical Action: Mechanical biofilm disruption (sharp debridement) combined with topical non-cytotoxic antimicrobials (cadexomer iodine, medical honey, polyhexamethylene biguanide [PHMB], silver formulations). Systemic antibiotics are strictly reserved for deep invasive tissue infection.

3. M: Moisture Imbalance

Exudate is a biological double-edged sword. In physiologic healing, wound fluid delivers electrolytes, nutrients, and autolytic enzymes. In chronic wounds, exudate volume and composition become pathological:

• Desiccation (Moisture Deficit): In dry wounds, cellular metabolism halts, cellular death occurs, growth factors denature, and the bed forms a rigid crust that impedes epithelial resurfacing.
• Maceration (Moisture Excess): In heavily exuding wounds (e.g., venous ulcers, infected wounds), excessive fluid leaks onto the periwound skin. Prolonged fluid exposure waterlogs the stratum corneum, dissolves the intercellular lipid mortar, activates skin kallikreins, and induces moisture-associated skin damage (MASD). Macerated skin appears pale, softened, wrinkled, and friable, rapidly eroding under trivial mechanical friction.
• Clinical Action: Exudate optimization via moisture-donating dressings (hydrogels) for desiccated wounds, or moisture-absorbing/wicking dressings (calcium alginates, hydrofibers, polyurethane foams, negative pressure wound therapy) for heavily exuding wounds.

4. E: Edge Non-Advancing or Undermined

In healthy acute repair, the wound margin shows an active, advancing epithelial tongue. In chronic wounds, margins frequently become stalled, thickened, undermined, or rolled (epibole):

• Cellular Senescence & Epibole: Basal keratinocytes at a chronic wound edge enter a state of phenotypic senescence. Despite exposure to mitogens, they exhibit blunted proliferation, shortened telomeres, and downregulated growth factor receptors (EGFR, PDGFR). When keratinocytes encounter an inhospitable, non-cleansed, or desiccated bed, their lateral migration is blocked. The cells continue to proliferate vertically, curling downward into the deep dermal margin until they make contact with basement membrane proteins beneath the edge, triggering contact inhibition and permanently halting advancement (epibole).
• Clinical Action: Sharply resecting or curetting the rolled, senescent edge ("freshening the margins") to expose responsive, non-senescent basal keratinocytes; applying extracellular matrices or cellular and tissue-based products (CTPs) to stimulate cellular migration.

---

The Expanded TIMERS Framework (2019 International Expert Panel)

In 2019, an international expert panel (Atkin et al., Journal of Wound Care) expanded the classic TIME framework to TIMERS, recognizing that local wound bed preparation must integrate modern regenerative biotherapies and holistic, patient-centered systemic management.

+-------------------------------------------------------------------------+
|                       THE EXPANDED TIMERS FRAMEWORK                     |
+-------------------------------------------------------------------------+
| [T] TISSUE         | Debridement of slough, eschar, and senescent matrix|
| [I] INFECTION      | Biofilm disruption, topical antiseptics, stewardship|
| [M] MOISTURE       | Exudate balance; prevention of maceration          |
| [E] EDGE           | Management of epibole, edge excision, MMP control  |
+--------------------+----------------------------------------------------+
| [R] REGENERATION   | Advanced biomaterials, CTPs, growth factors, NPWT  |
| [S] SOCIAL/SYSTEMIC| Perfusion, HbA1c, nutrition, offloading, compliance|
+-------------------------------------------------------------------------+

1. R: Regeneration & Repair

When a chronic wound fails to make adequate early progress—for example, less than about 50% area reduction after 4 weeks for a diabetic foot ulcer or about 40% for a venous leg ulcer despite optimal standard care—it is unlikely to close by 12 weeks. At this diagnostic crossroad, clinicians introduce advanced regenerative technologies:

• Cellular, Acellular & Matrix-like Products (CTPs / Skin Substitutes): Providing extracellular scaffolds (human acellular dermal matrix, porcine small intestinal submucosa, bovine collagen-elastin matrices, bilayered bioengineered living cellular constructs, and cryopreserved amniotic/placental membranes) that deliver structural collagen, fibronectin, glycosaminoglycans, and endogenous growth factors.
• Recombinant Growth Factors: Topical becaplermin (rhPDGF-BB 0.01% gel) for neuropathic diabetic foot ulcers.
• Autologous Cellular Therapies: Autologous platelet-rich plasma (PRP) and autologous epidermal/dermal micrografts.
• Biophysical Stimulation: Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), low-frequency non-contact ultrasound (LFUD), and pulsed electromagnetic field therapy.

2. S: Social, Systemic & Patient-Centered Factors

A wound cannot heal if the patient possessing the wound is neglected. The "S" pillar enforces systematic evaluation of systemic pathology, biomechanics, and psychosocial hurdles:

• Arterial Perfusion: Noninvasive arterial testing (Ankle-Brachial Index [ABI], Toe-Brachial Index [TBI], Transcutaneous Oxygen Tension [TcPO2]). Wounds cannot heal without adequate perfusion; significant ischemia should be evaluated for revascularization before advanced wound therapies.
• Metabolic & Glycemic Control: Individualized glycemic targets and avoiding acute glycemic variability to prevent advanced glycation end-product (AGE) accumulation, neutrophil paralysis, and microvascular basement membrane thickening.
• Nutritional Support: Screen for malnutrition and meet energy and protein needs (for example, about 1.25–1.5 g/kg/day of protein for adults with pressure injuries who are at risk); do not use prealbumin as a repletion target.
• Biomechanical Offloading: Absolute adherence to pressure redistribution (total contact casting [TCC] for neuropathic plantar ulcers; advanced alternating-pressure dynamic mattresses for sacral pressure injuries).
• Psychosocial & Economic Adherence: Smoking cessation (eliminating nicotine vasoconstriction and carbon monoxide hypoxemia), addressing financial toxicity, evaluating caregiver support, and selecting dressing change schedules compatible with the patient's cognitive and functional capabilities.

---

Wound Fluid Dynamics: Acute Mitogenic Milieu vs. Chronic Cytotoxic Microenvironment

The biological behavior of a wound bed is dictated by the biochemical composition of its fluid microenvironment. The transition from an acute healing state to a stalled chronic wound represents a catastrophic biochemical transformation:

===================================================================================
ACUTE WOUND FLUID (Mitogenic & Anabolic)
  [Intact PDGF, VEGF, bFGF, EGF] + [Controlled Low MMPs] + [High TIMP-1/2]
                              │
                              ▼
  Keratinocyte Migration  ──►  Fibroblast Proliferation  ──►  Robust Angiogenesis
===================================================================================
                                VS
===================================================================================
CHRONIC WOUND FLUID (Anti-Mitogenic & Catabolic)
  [Hyper-Elevated TNF-α, IL-1β] ──► [Markedly elevated MMP-8, MMP-9 & Neutrophil Elastase]
                              │
                              ▼
  Degradation of Growth Factors + Destruction of Fibronectin Scaffold + Cellular Apoptosis
===================================================================================

1. Acute Wound Fluid: Mitogenic & Pro-Angiogenic

Wound fluid harvested from clean surgical incisions or acute split-thickness donor sites promotes cellular regeneration:

• Mitogenic Stimulation: Acute wound fluid stimulates robust in vitro proliferation, thymidine incorporation, and DNA synthesis in human dermal fibroblasts, capillary endothelial cells, and basal keratinocytes.
• Intact Growth Factor Reservoir: Contains high concentrations of biologically active, intact growth factors (PDGF-AB/BB, VEGF-A, bFGF, TGF-beta-1, EGF).
• Controlled Proteolysis: Matrix metalloproteinases (MMP-1, MMP-8, MMP-9) are expressed in low, transient pulses strictly required for provisional matrix remodeling. Their catalytic activity is kept in check by an equimolar excess of Tissue Inhibitors of Metalloproteinases (TIMP-1 and TIMP-2).

2. Chronic Wound Fluid: Anti-Mitogenic, Cytotoxic & Proteolytic

Wound fluid aspirated from stalled venous leg ulcers, diabetic foot ulcers, or pressure injuries is highly toxic to cellular repair:

• Mitogenic Arrest & Cellular Senescence: When cultured with chronic wound fluid, normal fibroblasts and endothelial cells stop proliferating, downregulate cyclin-dependent kinases, exhibit morphological flattening, and enter premature cellular senescence or undergo apoptosis.
• The Proteolytic Storm: Chronic wound fluid displays a marked increase in matrix metalloproteinases—most notably neutrophil collagenase (MMP-8) and gelatinase B (MMP-9)—alongside massive elevations in serine proteases, specifically human neutrophil elastase (HNE). Concurrently, endogenous inhibitors (TIMPs) are severely degraded and depleted.
• Enzymatic Substrate Destruction: Uninhibited proteases digest both native and repair proteins indiscriminately:
  1. Destruction of Provisional ECM: Fibronectin, vitronectin, and laminin-332 are cleaved into inactive fragments, stripping the wound bed of cell-adhesion RGD (Arg-Gly-Asp) ligand motifs.
  2. Growth Factor Cleavage: Endogenous PDGF, VEGF, and TGF-beta are degraded within minutes of secretion.
  3. Receptor Inactivation: Transmembrane receptor tyrosine kinases (PDGFR, VEGFR, EGFR) on surviving fibroblasts and endothelial cells are cleaved at their extracellular binding domains, rendering cells completely blind to signaling molecules.
• Persistent Pro-Inflammatory Cytokine Drive: Chronic wound fluid harbors extreme, unresolving concentrations of TNF-α, IL-1β, and IL-6 produced by locked M1-polarized macrophages. These cytokines drive continuous NF-κB transcription, stimulating further neutrophil extravasation and degranulation while counter-regulatory anti-inflammatory cytokines (IL-10, IL-1Ra) remain completely suppressed.

Comprehensive Molecular Comparison: Acute vs. Chronic Wound Fluid

---

Clinical Traps & Practice Points for Wound Bed Preparation

Clinical Trap 1: The "Biologic Waste" Fallacy

Applying expensive bioengineered cellular constructs, dermal allografts, or recombinant human growth factors (rhPDGF-BB) to a wound bed that has not achieved TIME balance is an egregious clinical error. In a wound bed burdened with subclinical biofilm, heavy devitalized slough, or copious unmanaged exudate, elevated MMP-8, MMP-9, and neutrophil elastase will enzymatically degrade the exogenously applied graft within 24 to 48 hours. Practice Point: Advanced biologics and CTPs are strictly indicated under the "R" (Regeneration) pillar only after "T", "I", and "M" have been fully optimized.

Clinical Trap 2: Maceration Misdiagnosed as Cellulitis

Periwound skin subjected to chronic, unmanaged exudate develops severe maceration characterized by pale, waterlogged epidermis surrounded by an erythematous inflammatory halo and superficial weeping erosions. Inexperienced clinicians frequently misdiagnose this inflammatory reaction as advancing bacterial cellulitis and prescribe unnecessary systemic antibiotics. Practice Point: Cellulitis presents with asymmetrical, warm, indurated, tender, advancing erythema extending >2 cm from the margin without epidermal maceration. Periwound maceration resolves with barrier films (e.g., acrylate polymer films), vertical-wicking absorbent dressings, and compression—not systemic antibiotics.

Clinical Trap 3: The Dry Scab Misconception

Family members and non-wound clinicians often celebrate the formation of a hard, black, dry scab over an open wound as a sign of "healing." In reality, George Winter showed that moist wounds resurface about twice as fast as those under a dry scab; the scab forces keratinocytes to expend energy burrowing through healthy dermis, and creates an occluded, anaerobic sub-eschar space that conceals deep abscess formation and osteomyelitis.